- 期刊
Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study
延伸閱讀
- Bhargava, P., Lang, A., Louzi, O. A., Carass, A., Prince, J., Calabresi, P. A., & Saidha, S. (2015). Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials. Multiple Sclerosis International, 2015(), 3-12. https://doi.org/10.1155/2015/136295
- Ernst, A., Botzung, A., Gounot, D., Sellal, F., Blanc, F., Seze, J. D., & Manning, L. (2012). Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary Study. Multiple Sclerosis International, 2012(), 154-165. https://doi.org/10.1155/2012/820240
- Rabiei, L., Abedi, H., Abedi, P., Zarea, K., & Masoudi, R. (2017). Perspectives and Experiences Related to Help-Seeking Behaviors: A Content Analysis Study of Iranian Patients With Multiple Sclerosis. The Journal of Nursing Research, 25(3), 251-259. https://doi.org/10.1097/jnr.0000000000000216
- Yadav, V., Bourdette, D. N., Bowen, J. D., Lynch, S. G., Mattson, D., Preiningerova, J., Jr., C. T. B., Simon, J., Goldstein, A., Burrows, G. G., Offner, H., Ferro, A. J., & Vandenbark, A. A. (2012). Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Autoimmune Diseases, 2012(), 523-533. https://doi.org/10.1155/2012/954739
- Vickrey, B. G., Lee, L., Moore, F., & Moriarty, P. (2015). EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a. Multiple Sclerosis International, 2015(), 93-98. https://doi.org/10.1155/2015/631989